Argentos Pharma Private Limited
About Argentos Pharma Private Limited
Data last updated:
Argentos Pharma Private Limited is a private limited company based in Delhi, India. It was incorporated on 28 November 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U32500DL2023PTC423133.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10.71 Lakh. It is led by directors including Tapendra Vishnoi and Priti Gehlot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No – 312 Plot No – 5, R.G. Complex – II, Delhi, India – 110085.
Company details
Contact details
Argentos Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressUnit No – 312 Plot No – 5, R.G. Complex – II, Delhi, India – 110085
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Argentos Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Argentos Pharma Private Limited, buy the company report.
Board of directors of Argentos Pharma Private Limited
Argentos Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tapendra Vishnoi Also directs: Enviro Avsolutions LLP | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Mahesh Kumar Garg Also directs: Dr. Garg Diagnostic & Imaging Centre LLP | Additional Director | 26 Jun 2024 | 2 Years 3 Months | Current |
| Priti Gehlot | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Sunita Yadav Also directs: Medekon Medicity Private Limited | Additional Director | 05 Dec 2023 | 2 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Argentos Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Argentos Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Argentos Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Argentos Pharma Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Mahesh Kumar Garg was appointed as Additional Director on 26 Jun 2024.
Frequently asked questions
Argentos Pharma is an active private limited company based in Delhi, India. It was incorporated on 28 November 2023 (3+ years old) and is registered under CIN U32500DL2023PTC423133.
Argentos Pharma has 4 current directors:
- Tapendra Vishnoi - Director
- Mahesh Kumar Garg - Additional Director
- Priti Gehlot - Director
- Sunita Yadav - Additional Director
The latest financial statements of Argentos Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Argentos Pharma is U32500DL2023PTC423133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Argentos Pharma was incorporated on 28 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Mahesh Kumar Garg was appointed as Additional Director on 26 Jun 2024. Sunita Yadav was appointed as Additional Director on 05 Dec 2023. Priti Gehlot was appointed as Director on 28 Nov 2023. Argentos Pharma has 4 board changes on record in total.
The registered office of Argentos Pharma is at Unit No – 312 Plot No – 5, R.G. Complex – II, Delhi, India – 110085.
Argentos Pharma can be reached at its registered office: Unit No – 312 Plot No – 5, R.G. Complex – II, Delhi, India – 110085.
Argentos Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.